ClinicalTrials.gg
Drug

Patiromer clinical trials

Also written Veltassa and RLY5016.

studies test it
25
open now
3
in phase 3
6
first study started
2008

How each study uses patiromer is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the patiromer studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
21 Oct 2015 · VELTASSA · NDA 205739 (FDA, Drugs@FDA)
European Union
19 Jul 2017 · Veltassa · EMEA/H/C/004180 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Patiromer
16
RLY5016 for Oral Suspension
6
Patiromer Oral Product
2
Patiromer 8400 MG [Veltassa]
2

Brand

Veltassa
12

Development codes

RLY5016
2

Studies by the year they started

25 studies that test it; most in 2017 (4)

Studies that test patiromer, by start year
YearStudies
20081
20091
20101
20111
20131
20162
20174
20181
20194
20203
20211
20221
20231
20241
20252

By phase

A phase 1/2 study counts in both.

Phase 2
9
Phase 3
6
Phase 4
10

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 13 · Other 12

Relypsa, Inc. (7) · Vifor Pharma, Inc. (3) · Mario Negri Institute for Pharmacological Research (2) · Vifor Fresenius Medical Care Renal Pharma (1) · Duke University (1) · Wake Forest University Health Sciences (1) · Dominic Raj (1) · Oslo University Hospital (1)

Often tested with

Tested in the same studies.

Polyethylene glycol 3350 (1) · Polystyrene sulfonic acid (1) · Sodium zirconium cyclosilicate (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test patiromer.

Studies

Open first, then newest update. How each study uses patiromer is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 25

See all 25 studies that test patiromer →

Codes

What other systems call patiromer · ClinicalTrials.gg INT005946

  • MeSH (NLM) C568789patiromerOne source NLM
  • UNII (FDA) 1FQ2RY5YHHPATIROMERConfirmed FDA, NLM, Wikidata
  • RxNorm 1716203Confirmed FDA, Wikidata
  • Wikidata Q21284261patiromerConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C166500PatiromerOne source FDA
  • DrugBank DB09263One source Wikidata

Also registered as patiromer calcium (UNII 7T97I3787N) and patiromer sorbitex calcium (UNII 0LB9J2797D · RxNorm 2204723).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.